Has anyone completed a FMEA on the Box Picker or similar inventory management system that would share the findings? Much appreciated.

We are currently working on developing a downtime procedures for if/when our ADC (Pyxis) fails. If anyone is willing to share we would be greatful.
Thank you

Terrence Davidson BSP
Medication Safety Resource Pharmacist - Pharmacy Department
Royal University Hospital – Saskatoon Saskatchewan Canada
Saskatchewan Health Authority | 306-655-2274

We are focusing work in our ADC override rates and practices.

I wanted to verify how organizations were calculating their ADC override %s for metrics:

• # overrides / all ADC med vends or
• # overrides / all ADC vends for only meds that can be overridden

In creating tableau drilldowns by medication, I wanted to verify the denominator systems are using.

Thank you for weighing in!

Hi Everyone,

Is anyone willing to share their policies on a/b and ethanol locks? At our hospital, the CLABSI rate is increasing and we are reviewing if anyone is using a/b or ethanol locks different/prophylaxis for pts with documented central line infections. If you want you can post policy or protocols on discussion board or email pananthasingam@blythedale.org. Thank You for you help.

I'd be interested to know if anyone has any resource that has some basic questionnaires/tools to assess perceptions of medication safety climate among pharmacy team members. I beleive Knowing the baseline might give us pointers on how specifically to address further direction.
Thank you so much

Good Afternoon,

What strategies are you all employing to meet the updated NPSG.03.05.01 from The Joint Commission on anticoagulation that goes into effect July 1, 2019? Specifically around protocols/practice guidelines for reversal and perioperative management of anticoagulants.

Hi All
Our institution has recently completed a risk assessment on the use of epidurals in our L&D population (based on ISMP safety alert from 10/4/18). One of the recommendations from ISMP is to use 'unique neuraxial connectors.' When looking into these connectors (NRFit) it appears that they are 4x the cost of our typical epidural tubing (~$7/set vs ~$28/set).

How is your organization handling respirators? For example, if a CSTD is being used during IV administration of those medications that have the potential to vaporize at room temperature (i.e. carmustine, cisplatin, cyclophosphamide, etc.) are your nurses using respirators OR are you considering the CSTD the protection? Are you just using PAPR type respirators in the event of a spill? I appreciate your guidance!

Stacie Ethington, MSN, RN-BC
Medication Safety Nurse Specialist
Nebraska Medicine

Greetings - If you use a bladder instillation cocktail consisting of triamcinolone, heparin, lidocaine, gentamicin, and sodium bicarbonate in NS, are you able to share your BUD and the reference? Thank you.

We are in the process of implementing interoperability between smart pumps and EMR. During this process we have identified that our EMR is setup to have a dual verification for chemotherapy rate changes. This is not something that was forced before but when completing the pump rate verify it ask for each rate change to be dual verified.

The standards from ONS suggest a dual verification for initial pump programming but do not go into detail regarding rate changes. APON suggest a dual verification for initial pump programming and rate changes of chemotherapy.